{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:13:39Z","timestamp":1648991619123},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T00:00:00Z","timestamp":1252454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,9,9]],"date-time":"2009-09-09T00:00:00Z","timestamp":1252454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00104-009-1768-y","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T13:46:56Z","timestamp":1252936016000},"page":"934-946","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chirurgische Intensivmedizin"],"prefix":"10.1007","volume":"80","author":[{"given":"A.D.","family":"Niederbichler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ipaktchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jokuszies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Handschin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.H.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gellert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-U.","family":"Steinau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.M.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Steinstr\u00e4sser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,9]]},"reference":[{"key":"1768_CR1","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/01.CCM.0000261890.41311.E9","volume":"35","author":"Dombrovskiy","year":"2007","unstructured":"Dombrovskiy VY, Martin AA, Sunderram J, Paz HL (2007) Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 35:1244\u20131250","journal-title":"Crit Care Med"},{"key":"1768_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/cc2917","volume":"8","author":"Linde-Zwirble","year":"2004","unstructured":"Linde-Zwirble WT, Angus DC (2004) Severe sepsis epidemiology: sampling, selection, and society. Crit Care 8:222\u2013226","journal-title":"Crit Care"},{"key":"1768_CR3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","volume":"32","author":"Dellinger","year":"2004","unstructured":"Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32:858\u2013873","journal-title":"Crit Care Med"},{"key":"1768_CR4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","volume":"36","author":"Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296\u2013327","journal-title":"Crit Care Med"},{"key":"1768_CR5","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00003246-199107000-00024","volume":"19","author":"Bone","year":"1991","unstructured":"Bone RC (1991) Let\u2019s agree on terminology: definitions of sepsis. Crit Care Med 19:973\u2013976","journal-title":"Crit Care Med"},{"key":"1768_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00134-007-0934-2","volume":"34","author":"Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17\u201360","journal-title":"Intensive Care Med"},{"key":"1768_CR7","first-page":"181","volume":"8","author":"Marshall","year":"2006","unstructured":"Marshall JC (2006) The surviving sepsis campaign. Crit Care Resusc 8:181\u2013182","journal-title":"Crit Care Resusc"},{"key":"1768_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1472-6963-4-38","volume":"4","author":"Atkins","year":"2004","unstructured":"Atkins D, Eccles M, Flottorp S et al (2004) Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group. BMC Health Serv Res 4:38","journal-title":"BMC Health Serv Res"},{"key":"1768_CR9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/01.CCM.0000157787.24595.5B","volume":"33","author":"Engoren","year":"2005","unstructured":"Engoren M (2005) The effect of prompt physician visits on intensive care unit mortality and cost. Crit Care Med 33:727\u2013732","journal-title":"Crit Care Med"},{"key":"1768_CR10","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1097\/00003246-199806000-00019","volume":"26","author":"Lundberg","year":"1998","unstructured":"Lundberg JS, Perl TM, Wiblin T et al (1998) Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 26:1020\u20131024","journal-title":"Crit Care Med"},{"key":"1768_CR11","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368\u20131377","journal-title":"N Engl J Med"},{"key":"1768_CR12","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1097\/00003246-199810000-00014","volume":"26","author":"Dorman","year":"1998","unstructured":"Dorman T, Breslow MJ, Lipsett PA et al (1998) Radial artery pressure monitoring underestimates central arterial pressure during vasopressor therapy in critically ill surgical patients. Crit Care Med 26:1646\u20131649","journal-title":"Crit Care Med"},{"key":"1768_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1378\/chest.118.1.146","volume":"118","author":"Ibrahim","year":"2000","unstructured":"Ibrahim EH, Sherman G, Ward S et al (2000) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146\u2013155","journal-title":"Chest"},{"key":"1768_CR14","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1097\/00003246-200010000-00014","volume":"28","author":"Kollef","year":"2000","unstructured":"Kollef MH, Ward S, Sherman G et al (2000) Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit Care Med 28:3456\u20133464","journal-title":"Crit Care Med"},{"key":"1768_CR15","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589\u20131596","journal-title":"Crit Care Med"},{"key":"1768_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1097\/01.CCM.0000157788.20591.23","volume":"33","author":"Bourgoin","year":"2005","unstructured":"Bourgoin A, Leone M, Delmas A et al (2005) Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function. Crit Care Med 33:780\u2013786","journal-title":"Crit Care Med"},{"key":"1768_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/BF01683060","volume":"3","author":"Regnier","year":"1977","unstructured":"Regnier B, Rapin M, Gory G et al (1977) Haemodynamic effects of dopamine in septic shock. Intensive Care Med 3:47\u201353","journal-title":"Intensive Care Med"},{"key":"1768_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000542-200203000-00011","volume":"96","author":"Patel","year":"2002","unstructured":"Patel BM, Chittock DR, Russell JA, Walley KR (2002) Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 96:576\u2013582","journal-title":"Anesthesiology"},{"key":"1768_CR19","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1007\/s00134-006-0378-0","volume":"32","author":"Lauzier","year":"2006","unstructured":"Lauzier F, Levy B, Lamarre P, Lesur O (2006) Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 32:1782\u20131789","journal-title":"Intensive Care Med"},{"key":"1768_CR20","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"Dunser","year":"2003","unstructured":"Dunser MW, Mayr AJ, Ulmer H et al (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107:2313\u20132319","journal-title":"Circulation"},{"key":"1768_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"Russell","year":"2008","unstructured":"Russell JA, Walley KR, Singer J et al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877\u2013887","journal-title":"N Engl J Med"},{"key":"1768_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00003246-199603000-00026","volume":"24","author":"Rudis","year":"1996","unstructured":"Rudis MI, Basha MA, Zarowitz BJ (1996) Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 24:525\u2013537","journal-title":"Crit Care Med"},{"key":"1768_CR23","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1056\/NEJM199510193331601","volume":"333","author":"Gattinoni","year":"1995","unstructured":"Gattinoni L, Brazzi L, Pelosi P et al (1995) A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333:1025\u20131032","journal-title":"N Engl J Med"},{"key":"1768_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1056\/NEJM199902113400601","volume":"340","author":"Hebert","year":"1999","unstructured":"Hebert PC, Wells G, Blajchman MA et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409\u2013417","journal-title":"N Engl J Med"},{"key":"1768_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/cc1070","volume":"5","author":"Fernandes","year":"2001","unstructured":"Fernandes CJ Jr, Akamine N, De Marco FV et al (2001) Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 5:362\u2013367","journal-title":"Crit Care"},{"key":"1768_CR26","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1001\/jama.269.23.3024","volume":"269","author":"Marik","year":"1993","unstructured":"Marik PE, Sibbald WJ (1993) Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 269:3024\u20133029","journal-title":"JAMA"},{"key":"1768_CR27","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1378\/chest.116.5.1233","volume":"116","author":"Fransen","year":"1999","unstructured":"Fransen E, Maessen J, Dentener M et al (1999) Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 116:1233\u20131239","journal-title":"Chest"},{"key":"1768_CR28","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1001\/jama.288.22.2827","volume":"288","author":"Corwin","year":"2002","unstructured":"Corwin HL, Gettinger A, Pearl RG et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827\u20132835","journal-title":"JAMA"},{"key":"1768_CR29","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","volume":"286","author":"Warren","year":"2001","unstructured":"Warren BL, Eid A, Singer P et al (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869\u20131878","journal-title":"JAMA"},{"key":"1768_CR30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","volume":"317","author":"Bone","year":"1987","unstructured":"Bone RC, Fisher CJ Jr, Clemmer TP et al (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317:653\u2013658","journal-title":"N Engl J Med"},{"key":"1768_CR31","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","volume":"23","author":"Cronin","year":"1995","unstructured":"Cronin L, Cook DJ, Carlet J et al (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23:1430\u20131439","journal-title":"Crit Care Med"},{"key":"1768_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM198709103171102","volume":"317","author":"The","year":"1987","unstructured":"The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317:659\u2013665","journal-title":"N Engl J Med"},{"key":"1768_CR33","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"Annane","year":"2002","unstructured":"Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862\u2013871","journal-title":"JAMA"},{"key":"1768_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1210\/jc.77.1.151","volume":"77","author":"Reincke","year":"1993","unstructured":"Reincke M, Allolio B, Wurth G, Winkelmann W (1993) The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 77:151\u2013156","journal-title":"J Clin Endocrinol Metab"},{"key":"1768_CR35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200608-1079OC","volume":"175","author":"Sprung","year":"2007","unstructured":"Sprung CLAD, Briegel J et al (2007) Corticosteroid therapy of septic shock (CORTICUS). Am Rev Respir Crit Care Med 175:507 (Abstr)","journal-title":"Am Rev Respir Crit Care Med"},{"key":"1768_CR36","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1097\/01.CCM.0000114816.62331.08","volume":"32","author":"Angus","year":"2004","unstructured":"Angus DC, Laterre PF, Helterbrand J et al (2004) The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 32:2199\u20132206","journal-title":"Crit Care Med"},{"key":"1768_CR37","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699\u2013709","journal-title":"N Engl J Med"},{"key":"1768_CR38","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/00003246-200111000-00003","volume":"29","author":"Bernard","year":"2001","unstructured":"Bernard GR, Ely EW, Wright TJ et al (2001) Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med 29:2051\u20132059","journal-title":"Crit Care Med"},{"key":"1768_CR39","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa050935","volume":"353","author":"Abraham","year":"2005","unstructured":"Abraham E, Laterre PF, Garg R et al (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332\u20131341","journal-title":"N Engl J Med"},{"key":"1768_CR40","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1097\/01.CCM.0000181729.46010.83","volume":"33","author":"Vincent","year":"2005","unstructured":"Vincent JL, Bernard GR, Beale R et al (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Crit Care Med 33:2266\u20132277","journal-title":"Crit Care Med"},{"key":"1768_CR41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/ajrccm.165.2.2108087","volume":"165","author":"Frank","year":"2002","unstructured":"Frank JA, Gutierrez JA, Jones KD et al (2002) Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 165:242\u2013249","journal-title":"Am J Respir Crit Care Med"},{"key":"1768_CR42","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/cc1829","volume":"7","author":"Frank","year":"2003","unstructured":"Frank JA, Matthay MA (2003) Science review: mechanisms of ventilator-induced injury. Crit Care 7:233\u2013241","journal-title":"Crit Care"},{"key":"1768_CR43","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1164\/rccm.200605-621OC","volume":"175","author":"Hirsch","year":"2007","unstructured":"Hirsch J, Hansen KC, Sapru A et al (2007) Impact of low and high tidal volumes on the rat alveolar epithelial type II cell proteome. Am J Respir Crit Care Med 175:1006\u20131013","journal-title":"Am J Respir Crit Care Med"},{"key":"1768_CR44","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/cc695","volume":"4","author":"Pinsky","year":"2000","unstructured":"Pinsky MR (2000) Toward a better ventilation strategy for patients with acute lung injury. Crit Care 4:205\u2013206","journal-title":"Crit Care"},{"key":"1768_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/rr15","volume":"1","author":"Slutsky","year":"2000","unstructured":"Slutsky AS, Ranieri VM (2000) Mechanical ventilation: lessons from the ARDSNet trial. Respir Res 1:73\u201377","journal-title":"Respir Res"},{"key":"1768_CR46","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","volume":"342","author":"The","year":"2000","unstructured":"The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301\u20131308","journal-title":"N Engl J Med"},{"key":"1768_CR47","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1097\/00003246-199912000-00001","volume":"27","author":"Brook","year":"1999","unstructured":"Brook AD, Ahrens TS, Schaiff R et al (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27:2609\u20132615","journal-title":"Crit Care Med"},{"key":"1768_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/jpepsy\/17.1.95","volume":"17","author":"Ambuel","year":"1992","unstructured":"Ambuel B, Hamlett KW, Marx CM, Blumer JL (1992) Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol 17:95\u2013109","journal-title":"J Pediatr Psychol"},{"key":"1768_CR49","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","volume":"289","author":"Ely","year":"2003","unstructured":"Ely EW, Truman B, Shintani A et al (2003) Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 289:2983\u20132991","journal-title":"JAMA"},{"key":"1768_CR50","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1056\/NEJM200005183422002","volume":"342","author":"Kress","year":"2000","unstructured":"Kress JP, Pohlman AS, O\u2019Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 342:1471\u20131477","journal-title":"N Engl J Med"},{"key":"1768_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00003246-199701000-00015","volume":"25","author":"Freebairn","year":"1997","unstructured":"Freebairn RC, Derrick J, Gomersall CD et al (1997) Oxygen delivery, oxygen consumption, and gastric intramucosal pH are not improved by a computer-controlled, closed-loop, vecuronium infusion in severe sepsis and septic shock. Crit Care Med 25:72\u201377","journal-title":"Crit Care Med"},{"key":"1768_CR52","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","volume":"31","author":"Van","year":"2003","unstructured":"Van den Berghe G, Wouters PJ, Bouillon R et al (2003) Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 31:359\u2013366","journal-title":"Crit Care Med"},{"key":"1768_CR53","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"van","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359\u20131367","journal-title":"N Engl J Med"},{"key":"1768_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/00005373-199904000-00011","volume":"46","author":"Marx","year":"1999","unstructured":"Marx WH, DeMaintenon NL, Mooney KF et al (1999) Cost reduction and outcome improvement in the intensive care unit. J Trauma 46:625\u2013629; discussion 629\u2013630","journal-title":"J Trauma"},{"key":"1768_CR55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa052521","volume":"354","author":"Van","year":"2006","unstructured":"Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449\u2013461","journal-title":"N Engl J Med"},{"key":"1768_CR56","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1001\/jama.290.15.2041","volume":"290","author":"Finney","year":"2003","unstructured":"Finney SJ, Zekveld C, Elia A, Evans TW (2003) Glucose control and mortality in critically ill patients. JAMA 290:2041\u20132047","journal-title":"JAMA"},{"key":"1768_CR57","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.4065\/78.12.1471","volume":"78","author":"Krinsley","year":"2003","unstructured":"Krinsley JS (2003) Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 78:1471\u20131478","journal-title":"Mayo Clin Proc"},{"key":"1768_CR58","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00000542-200608000-00006","volume":"105","author":"Egi","year":"2006","unstructured":"Egi M, Bellomo R, Stachowski E et al (2006) Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology 105:244\u2013252","journal-title":"Anesthesiology"},{"key":"1768_CR59","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1023\/A:1018810325370","volume":"42","author":"Levy","year":"1997","unstructured":"Levy MJ, Seelig CB, Robinson NJ, Ranney JE (1997) Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 42:1255\u20131259","journal-title":"Dig Dis Sci"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-009-1768-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-009-1768-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-009-1768-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-009-1768-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T16:12:04Z","timestamp":1589472724000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-009-1768-y"}},"subtitle":["Aktuelle Therapiekonzepte septischer Erkrankungen"],"short-title":[],"issued":{"date-parts":[[2009,9,9]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1007\/s00104-009-1768-y","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,9]]},"assertion":[{"value":"9 September 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}